MetaCap

Decoy Therapeutics (DCOY) vs Psyence Biomedical (PBM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Relative performance

DCOY-8.70%PBM+1.84%
+6%-2%-9%
Oct 7, 20261 yearOct 9, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DCOY versus PBM key metrics
MetricDCOYPBM
Share price$1.47$4.97
Market cap$3.51M—
1-day change-3.29%-2.93%
YTD return—-83.10%
1-year return—-96.56%
P/E ratio (TTM)0.12—
EPS (TTM)$12.32$-12.56
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$55.92$150.78
52-week low$1.46$1.92
Distance from 52-week high-97.37%-96.70%
Analyst consensusstrong_buy—
Avg. price target upside+104.08%—
Average volume2.20M94.85K
Shares outstanding2.39M—
Employees1112
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Decoy Therapeutics

DCOY stock →

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company.

Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees

About Psyence Biomedical

PBM stock →

Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting.

Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees

DCOY vs PBM FAQ

Are Decoy Therapeutics and Psyence Biomedical in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons